Literature DB >> 16602276

Effects of antiglaucoma drugs on cellular proliferation in cultured human corneal keratocytes.

Kwou-Yeung Wu1, Hwei-Zu Wang, Show-Jen Hong.   

Abstract

The purpose of this study was to investigate the effects of various antiglaucoma drugs, including timolol, betaxolol, carteolol, levobunolol, dipivefrin, and pilocarpine, on cellular proliferation in cultured human corneal keratocytes. Human corneal keratocytes were cultured with RPMI-1640 medium containing 10% fetal bovine serum. Antiglaucoma drugs were prepared from original concentrations to dilutions of 1/10, 1/100, and 1/1,000. After exposure to drugs for 100 minutes, cellular proliferation was estimated by [3H]thymidine uptake methodology. It was found that cellular proliferation in corneal keratocytes was inhibited by only a 1/10 dilution of various drugs including timolol, betaxolol, carteolol, levobunolol, dipivefrin, and pilocarpine. The [3H]thymidine uptake values were significantly inhibited to 63%, 18%, 87%, 68%, 55%, and 67% by a 1/10 dilution of the above drugs. However, the cellular proliferation was also significantly suppressed by 0.01 mg/mL of benzalkonium chloride preservative. It is shown that the inhibition of cellular proliferation by high concentrations of antiglaucoma drugs may result from the benzalkonium chloride preservative contained in these drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16602276     DOI: 10.1016/S1607-551X(09)70231-1

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  2 in total

1.  [A comparative in vitro analysis of primary and immortalized keratocytes].

Authors:  L Kagan; P W Rieck
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

2.  Cytometric assessment of cytostatic and cytotoxic effects of topical glaucoma medications on human epithelial corneal line cells.

Authors:  Dorota Pozarowska; Piotr Pozarowski; Zbigniew Darzynkiewicz
Journal:  Cytometry B Clin Cytom       Date:  2010-03       Impact factor: 3.058

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.